Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sustained effects of single doses of classical psychedelics in humans
Gitte M. Knudsen
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 145-150
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference
Н. К. Попова, А. С. Цыбко, В. С. Науменко
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8814-8814
Open Access | Times Cited: 50
Psychedelics and Neural Plasticity: Therapeutic Implications
Steven F. Grieco, Eero Ċastrén, Gitte M. Knudsen, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8439-8449
Open Access | Times Cited: 44
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Psychedelics and sexual functioning: a mixed-methods study
Tommaso Barba, Hannes Kettner, Caterina Radu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
Drummond E-Wen McCulloch, Matthias E. Liechti, Kim P. C. Kuypers, et al.
Neuroscience Applied (2024) Vol. 3, pp. 103938-103938
Open Access | Times Cited: 5
Exploring Psychedelics for Unmet Needs in Women’s Reproductive Health
Sara Shoar, Alissa Bazinet, Chaitra Jairaj
Psychedelic Medicine (2025)
Closed Access
Phenethylaminylation: Preliminary In Vitro Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model Compound
Rajiv Rangan, Russell Petty, Suchismita Acharya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Is There Room for Ethics of Authenticity in Psilocybin Research?
Stefan Jerotić
Neuroscience Applied (2025), pp. 105519-105519
Open Access
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 11
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 17
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 733-754
Closed Access | Times Cited: 7
Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies
Patrick Fissler, Anja Vandersmissen, Marco Filippi, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 679-686
Closed Access | Times Cited: 5
Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies
Maya Armstrong, Joel Castellanos, Devon Christie
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 1
Stutterers’ experiences on classic psychedelics: A preliminary self-report study
Eric S. Jackson, Noam Goldway, Hope Gerlach, et al.
Journal of Fluency Disorders (2024) Vol. 81, pp. 106062-106062
Closed Access | Times Cited: 1
Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
Frederick A. Bagdasarian, Hanne D. Hansen, Jingyuan Chen, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2654-2661
Closed Access | Times Cited: 1
Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms
Friederike Holze, Matthias E. Liechti, Felix Müller
Current topics in behavioral neurosciences (2024)
Closed Access | Times Cited: 1
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 1
A psilocybin haven: the use of comparison to legitimate transgression at a psychedelic retreat
Jesper Dunell
Drugs Education Prevention and Policy (2024), pp. 1-9
Open Access | Times Cited: 1
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Laith Alexander, David J. Anderson, Luke Baxter, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
An investigation of acute Physiological and Psychological Moderators of Psychedelic-induced Personality Change among Healthy Volunteers
Kate Godfrey, Brandon Weiss, Xinwei Zhang, et al.
Neuroscience Applied (2024), pp. 104092-104092
Open Access | Times Cited: 1
Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
P. Deepak Raj, Shyambabu Rauniyar, Bhagyesh Sapkale
Cureus (2023)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top